Live Quote · NASDAQBVXVHealthcare· Biotechnology

BiondVax Pharmaceuticals Ltd.

$1.36 0.74%(+$0.01)
TickerSpark Score
60/100
Mixed
80
Valuation
40
Profitability
60
Growth
68
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BVXV research report →

52-Week Range7% of range
Low
$0.63
Current
$1.36
High
$11.49
Company Overviewwww.biondvax.com

About the company

BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions.

CEO
Amir Reichman
IPO
2015
Employees
33
HQ
Jerusalem, IL

Price Chart

-88.57% · this period
$10.96$5.88$0.80Oct 03Apr 04Oct 03
Valuation
Market Cap
$4.97M
P/E
-19.86
P/S
0.00
P/B
-5.99
EV/EBITDA
-2.13
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-4.92%
ROIC
-4.04%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-531,000 · 98.95%
EPS
$-0.20 · 99.44%
Op Income
$-11,061,000
FCF YoY
67.48%
Performance & Tape
52W High
$11.49
52W Low
$0.63
50D MA
$1.17
200D MA
$1.79
Beta
2.37
Avg Volume
38.94K

Get TickerSpark's AI analysis on BVXV

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 1, 23MARGOLIN YAELother133,200
Jan 1, 23MARGOLIN YAELother0
Jan 1, 23Laster Morris Cother133,200
Jan 1, 23Laster Morris Cother0
Jan 1, 23Lowell Georgeother1,000,000
Jan 1, 23Rotman Avnerother133,200
Jan 1, 23Rotman Avnerother0
Jan 1, 23Rotman Avnerother0
Jan 1, 23Moed Samuel Jother3,280,000
Jan 1, 23Green Jayother1,000,000
Coverage · BVXV

Our BVXV coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on BVXV yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate BVXV report →
Internal Compare

Similar companies

Peers in the same neighborhood.